Details for Patent: 9,757,394
✉ Email this page to a colleague
Which drugs does patent 9,757,394 protect, and when does it expire?
Patent 9,757,394 protects CAROSPIR and is included in one NDA.
This patent has four patent family members in four countries.
Summary for Patent: 9,757,394
Title: | Spironolactone aqueous formulations |
Abstract: | Disclosed herein is a pharmaceutical composition, comprising: (a) spironolactone; (b) a xanthan gum; (c) an anti-foaming agent; (d) a preservative; (f) a dispersing agent; (g) a sweetening agent; (h) a flavoring agent; (i) optionally a buffer to maintain the pH of the pharmaceutical composition within a range described herein; and (j) a sufficient amount of a water vehicle. |
Inventor(s): | Pipho; Anthony (Winterville, NC), DeHart; Michael Paul (Winterville, NC) |
Assignee: | CMP DEVELOPMENT LLC (Farmville, NC) |
Application Number: | 15/337,559 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,757,394 |
Patent Claim Types: see list of patent claims | Use; Composition; Process; Delivery; |
Drugs Protected by US Patent 9,757,394
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | CAROSPIR IS INDICATED FOR TREATMENT OF NYHA CLASS III-IV HEART FAILURE AND REDUCED EJECTION FRACTION TO INCREASE SURVIVAL, MANAGE EDEMA, AND TO REDUCE THE NEED FOR HOSPITALIZATION FOR HEART FAILURE | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,757,394
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 3003028 | ⤷ Try a Trial | |||
European Patent Office | 3368045 | ⤷ Try a Trial | |||
Morocco | 43132 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 2017075463 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |